Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (441-450 of 1,376) with videos related to

Pageof 138
Sort By:
Drug Development Research|October 16, 2014
Visualization of plasma and tissue binding using dose fractions parameterAndreas Svennebring
Drug Development Research|October 16, 2014
Comparison of antidepressant-like and abuse-related effects of phencyclidine in ratsTodd M Hillhouse, Joseph H Porter, S Stevens Negus
Drug Development Research|November 20, 2014
Inhibition of LPS-induced TLR4 signaling products in murine macrophages by phenylmethimazole: an assay methodology for screening potential phenylmethimazole analogsSudhir P Deosarkar, Pooja Bhatt, Jessica Gillespie, et al.
Drug Development Research|January 17, 2020
Novel 3-aryl-5-substituted-coumarin analogues: Synthesis and bioactivity profileEleni Kavetsou, Annita Katopodi, Letta Argyri, et al.
Drug Development Research|November 10, 2020
ERRATUM
Drug Development Research|September 8, 2020
New multitarget directed benzimidazole-2-thiol-based heterocycles as prospective anti-radical and anti-Alzheimer's agentsAbdul Latif, Samina Bibi, Sardar Ali, et al.
Drug Development Research|November 2, 2020
"Azole" as privileged heterocycle for targeting the inducible cyclooxygenase enzymeParteek Prasher, Mousmee Sharma
Drug Development Research|November 7, 2019
Aza-CGP37157-lipoic hybrids designed as novel Nrf2-inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation inhibitory propertiesPatrycja Michalska, Giammarco Tenti, Michelle Satriani, et al.
Drug Development Research|November 8, 2019
Novel 5-(1-aryl-1H-pyrazol-3-yl)-1H-tetrazoles as glycogen phosphorylase inhibitors: An in vivo antihyperglycemic activity studyPramod P Kattimani, Shilpa M Somagond, Praveen K Bayannavar, et al.
Drug Development Research|March 5, 2020
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeuticsDavid Gurwitz
Pageof 138

Showing results (441-450 of 1,376) with videos related to

Sort By:
Pageof 138
Drug Development Research|October 16, 2014
Visualization of plasma and tissue binding using dose fractions parameterAndreas Svennebring
Drug Development Research|October 16, 2014
Comparison of antidepressant-like and abuse-related effects of phencyclidine in ratsTodd M Hillhouse, Joseph H Porter, S Stevens Negus
Drug Development Research|November 20, 2014
Inhibition of LPS-induced TLR4 signaling products in murine macrophages by phenylmethimazole: an assay methodology for screening potential phenylmethimazole analogsSudhir P Deosarkar, Pooja Bhatt, Jessica Gillespie, et al.
Drug Development Research|January 17, 2020
Novel 3-aryl-5-substituted-coumarin analogues: Synthesis and bioactivity profileEleni Kavetsou, Annita Katopodi, Letta Argyri, et al.
Drug Development Research|November 10, 2020
ERRATUM
Drug Development Research|September 8, 2020
New multitarget directed benzimidazole-2-thiol-based heterocycles as prospective anti-radical and anti-Alzheimer's agentsAbdul Latif, Samina Bibi, Sardar Ali, et al.
Drug Development Research|November 2, 2020
"Azole" as privileged heterocycle for targeting the inducible cyclooxygenase enzymeParteek Prasher, Mousmee Sharma
Drug Development Research|November 7, 2019
Aza-CGP37157-lipoic hybrids designed as novel Nrf2-inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation inhibitory propertiesPatrycja Michalska, Giammarco Tenti, Michelle Satriani, et al.
Drug Development Research|November 8, 2019
Novel 5-(1-aryl-1H-pyrazol-3-yl)-1H-tetrazoles as glycogen phosphorylase inhibitors: An in vivo antihyperglycemic activity studyPramod P Kattimani, Shilpa M Somagond, Praveen K Bayannavar, et al.
Drug Development Research|March 5, 2020
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeuticsDavid Gurwitz
Pageof 138